Showing results (871-880 of 922) with videos related to

Sort By:
Pageof 93
Blood|February 7, 2025
Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b studyIoannis Mantzaris, Mendel Goldfinger, Matan Uriel, et al.
The Journal of Investigative Dermatology|June 8, 2007
Multiple self-healing squamous epithelioma in different ethnic groups: more than a founder mutation disorder?Mariella D'Alessandro, Stephanie E Coats, Susan M Morley, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancersNabamita Boruah, David Hoyos, Renyta Moses, et al.
Nature Communications|May 21, 2026
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancersNabamita Boruah, David Hoyos, Renyta Moses, et al.
Leukemia|June 13, 2008
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemiaE J Feldman, J Cortes, D J DeAngelo, et al.
Molecular Cancer Therapeutics|May 6, 2015
Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in GlioblastomaIra K Gordon, Jie Lu, Christian A Graves, et al.
Blood|September 26, 2007
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5qAzra Raza, James A Reeves, Eric J Feldman, et al.
Molecular Cancer Therapeutics|November 17, 2017
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid LeukemiaFu Li, May Kung Sutherland, Changpu Yu, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|May 26, 2018
A Comparative Study of the ReCell® Device and Autologous Spit-Thickness Meshed Skin Graft in the Treatment of Acute Burn InjuriesJames Hill Holmes Iv, Joseph A Molnar, Jeffrey E Carter, et al.
Blood|October 24, 2002
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)John C Byrd, Krzysztof Mrózek, Richard K Dodge, et al.
Pageof 93